2014Ovidius University Annals Economic Sciences SeriesOpen access

A New Vision Regarding the Competitive Advantages in the Romanian Pharmaceutical Market

Doina Margaritti

Open full text 0 citations

Abstract

Competition in the pharmaceutical industry assures maximum efficiency regarding the use of a company’s capital in comparison to other competitors that have the same sphere of activity. Creating and maintaining a competitive advantage in the pharmaceutical market is achieved through measures, specific methods that are used by companies in the pharmaceutical industry like planning and production strategies, an efficient use of raw materials, innovative research and development activities and through specializing the work force, thus determining a higher efficiency for the players in this field and an increased efficiency obtained by the competing companies. The new competitive advantage concept is based primary on active, selective policies that are directed to achieve certain targets in the pharmaceutical markets competitiveness, which is focused on four pillars: the company, the competition, the favourable national environment and the adequate economic policies that are oriented and applied to the drug producing companies, the state institutions and the European Union organisations.

About this research paper

What this paper is about

Competition in the pharmaceutical industry assures maximum efficiency regarding the use of a company’s capital in comparison to other competitors that have the same sphere of activity. Creating and maintaining a competitive advantage in the pharmaceutical market is achieved through measures, specific methods that are used by companies in the pharmaceutical industry like planning and production strategies, an efficient use of raw materials, innovative research and development activities and through specializing the work force, thus determining a higher efficiency for the players in this field and an increased efficiency obtained by the competing companies. The new competitive advantage concept is based primary on active, selective policies that are directed to achieve certain targets in the pharmaceutical markets competitiveness, which is focused on four pillars: the company, the competition, the favourable national environment and the adequate economic policies that are oriented and applied to the drug producing companies, the state institutions and the European Union organisations.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Competition in the pharmaceutical industry assures maximum efficiency regarding the use of a company’s capital in comparison to other competitors that have the same sphere of activity. Creating and maintaining a competitive advantage in the pharmaceutical market is achieved through measures, specific methods that are used by companies in the pharmaceutical industry like planning and production strategies, an efficient use of raw materials, innovative research and development activities and through specializing the work force, thus determining a higher efficiency for the players in this field and an increased efficiency obtained by the competing companies. The new competitive advantage concept is based primary on active, selective policies that are directed to achieve certain targets in the pharmaceutical markets competitiveness, which is focused on four pillars: the company, the competition, the favourable national environment and the adequate economic policies that are oriented and applied to the drug producing companies, the state institutions and the European Union organisations.

Key concepts: Competitor analysis, Competition (biology), Industrial organization, Competitive advantage, Pharmaceutical industry, Business, Production (economics), Romanian

Related papers

Back to paper searchBrowse research topicsOriginal source
A New Vision Regarding the Competitive Advantages in the Romanian Pharmaceutical Market — Research Paper | ScholarLens